Most people with MS who are treated with formulations of botulinum toxin to manage spasticity report being satisfied, a study ...

Columnist Desiree Lama explores how living with MS led her to confront the comparison trap, ultimately finding strength in ...

U.S. and Chinese researchers appear to have unlocked a novel way to stop T cells from attacking the body in MS and other ...

Nearly two-thirds of MS patients showed no signs of disability progression five years after having a stem cell transplant, a ...

Researchers at the Karolinska Institute in Sweden have identified 18 new potential drug targets for treating multiple ...

Talking to children about a parent’s multiple sclerosis diagnosis can help ease fears and keep your kids feeling connected.

A trial using PET scans to test the anti-inflammatory drug PIPE-791 finished enrolling healthy volunteers and patients with ...

In healthy adults, a single low dose of IMP761 continues to be safe and appears to reduce the activity of T-cells, a clinical ...

People with multiple sclerosis have a higher risk of developing dementia than the general population, a meta-analysis reports ...

A new low-cost generic form of Tecfidera is available in the U.S. for people with relapsing forms of MS for a fraction of the ...

Older men with MS who used androgen-modifying therapies showed unexpectedly sustained or increased disease activity in a ...

Mitochondrial abnormalities, or problems in cells' powerhouses, contribute to nerve cell death linked to motor control in MS, ...